The US market dominated the North America Pneumatic Tourniquet Market by country in 2023, and is projected to continue to be a dominant market till 2031; thereby, achieving a market value of $164.15 millions by 2031. The Canada market is experiencing a CAGR of 8.7% during 2024-2031. Additionally, the Mexico market would exhibit a CAGR of 7.8% during 2024-2031.
In cases of traumatic limb injuries with significant bleeding, these tourniquets provide rapid and effective control of haemorrhage, allowing for stabilization and transport to advanced medical facilities. They are used by first responders to manage bleeding at the scene of an accident or injury, ensuring that patients are stabilized before reaching the hospital. In military and field settings, these tourniquets are crucial for managing battlefield injuries and saving lives by controlling bleeding in high-pressure situations.
In addition, by providing a bloodless field, they help surgeons perform intricate procedures with greater precision, such as skin grafts, reconstructive surgeries, and cosmetic enhancements. Reducing blood flow to the surgical area helps control bleeding and minimize postoperative swelling, contributing to better outcomes and quicker recovery. In diagnostic imaging or interventional procedures, controlling blood flow can enhance the visibility of tissues and structures, leading to more accurate results. They are used in vascular studies to create a controlled environment for assessing blood flow and diagnosing vascular conditions.
The demand for these tourniquets has significantly increased due to the many surgical procedures in the United States. With millions of surgeries conducted annually, from elective orthopedic procedures to emergency interventions, there is a consistent and growing need for tourniquets to manage blood flow effectively. As per the Centers for Diseases Control and Prevention, in 2023, the total number of procedures conducted in the USA was 51.4 million. Of these, 719,000 were total knee replacements, and 332,000 were total hip replacements. Furthermore, the expansion of the medical device industry is linked to a rise in surgical procedures. With more surgeries being performed, the need for reliable and advanced tourniquets increases. This demand drives market growth and encourages the development of innovative solutions. According to the International Trade Administration (ITA), in 2022, Canada’s medical device industry size was estimated to be US$6.8 billion. The medical device industry is expected to grow 5.4% annually until 2028. In conclusion, the region's high numbers of surgical procedures and the increasing medical device industry are driving the market's growth.
Based on Type, the market is segmented into Single Bladder Tourniquet, and Double Bladder Tourniquet. Based on Application, the market is segmented into Intravenous Regional Anesthesia, Orthopedic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Ane-c Aid Ltd.
- Stryker Corporation
- VBM Medizintechnik GmbH
- Zimmer Biomet Holdings, Inc.
- SPENGLER HOLTEX Group
- Shanghai Huifeng Medical Instrument Co., Ltd.
- Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group)
- The Seaberg Company Inc. (SAM Medical)
- Hammarplast Medical AB
- OHK Medical Devices, Inc.
Market Report Segmentation
By Type
- Single Bladder Tourniquet
- Double Bladder Tourniquet
By Application
- Intravenous Regional Anesthesia
- Orthopedic
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Companies Mentioned
- Ane-c Aid Ltd.
- Stryker Corporation
- VBM Medizintechnik GmbH
- Zimmer Biomet Holdings, Inc.
- SPENGLER HOLTEX Group
- Shanghai Huifeng Medical Instrument Co., Ltd.
- Jiangsu Qianjing Medical Equipment Co.,Ltd (Jiangsu Qianjing Technology Development Group)
- The Seaberg Company Inc. (SAM Medical)
- Hammarplast Medical AB
- OHK Medical Devices, Inc.
Methodology
LOADING...